Table 1.
Baseline demographic and disease characteristics
| Variable, median (range) or n (%) | n = 18 |
| Sex | |
| Female | 6 (33.3) |
| Male | 12 (66.7) |
| Age | 37 years (19–69) |
| Body weight | 55 kg (40–72) |
| Disease duration | 44 months (12–160) |
| Disease type | |
| Extensive | 14 (77.7) |
| Left-sided | 4 (22.3) |
| Severity | |
| Severe | 4 (22.3) |
| Moderate | 14 (77.7) |
| Mild | 0 |
| Admission status | 10/18 (55.5) |
| History of emergency hospitalization | 2 times (0–3) |
| Lichtiger index | 8 (6–12) |
| UCEIS | 5 (4–8) |
| Hemoglobin (g/dL) | 11.4 (8.6–15.5) |
| Albumin (g/dL) | 3.4 (2.1–4.2) |
| C-reactive protein (mg/dL) | 1.04 (0.02–5.42) |
| Corticosteroid | |
| Refractory | 10 (55.5) |
| Dependent | 8 (44.5) |
| Use of immunomodulator | 4 (22.3) |
| Previous biologics failure | 15 (83.3) |
| 1 agent | 6 (33.3) |
| 2 agents | 7 (38.8) |
| 3 agents | 2 (11.1) |
| Previous calcineurin inhibitor failure | 8 (44.5) |